ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination

por Adams, Alexandra M., Vreeland, Timothy J., Clifton, Guy T., Peoples, George E.
Publicado 2021

Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

por Greene, Julia, Schneble, Erika, Berry, John, Trappey, Alfred, Vreeland, Timothy, Clifton, Guy, McGuire, William, Maxwell, George, Ponniah, Sathibalan, Peoples, George
Publicado 2014

Using Technology to Maintain the Education of Residents During the COVID-19 Pandemic

por Chick, Robert Connor, Clifton, Guy Travis, Peace, Kaitlin M., Propper, Brandon W., Hale, Diane F., Alseidi, Adnan A., Vreeland, Timothy J.
Publicado 2020

The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients

por Jácome, Alexandre A., Vreeland, Timothy J., Johnson, Benny, Kawaguchi, Yoshikuni, Wei, Steven H., Nancy You, Y., Vilar, Eduardo, Vauthey, Jean-Nicolas, Eng, Cathy
Publicado 2020

Maximizing Benefit of Virtual Learning: Lessons From the Coronavirus Disease 2019 Pandemic

por Carpenter, Elizabeth L., Adams, Alexandra M., Chick, Robert C., Stull, Mamie C., Hale, Diane F., Propper, Brandon W., Clifton, Guy T., Vreeland, Timothy J.
Publicado 2022

Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients

por Berry, John S, Schneble, Erika J, Trappey, Alfred F, Vreeland, Timothy J, Clifton, Guy T, Hale, Diane F, Sears, Alan K, Ponniah, Sathibalan, Mittendorf, Elizabeth A, Peoples, George E
Publicado 2013

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine

por Jackson, Doreen, Qiao, Na, Greene, Julia M, Hale, Diane, Berry, John, Trappey, Alfred, Vreeland, Timothy, Clifton, Guy, Ibrahim, Nuhad, Toms, Annie, Peoples, George E, Mittendorf, Elizabeth A
Publicado 2015

Analysis of Clinical and Pathologic Factors of Pure, Flat Epithelial Atypia on Core Needle Biopsy to Aid in the Decision of Excision or Observation

por Berry, John S, Trappey, Alfred F, Vreeland, Timothy J, Pattyn, Adam R, Clifton, Guy T, Berry, Elizabeth A, Schneble, Erika J, Kirkpatrick, Aaron D, Saenger, Jeffrey S, Peoples, George E
Publicado 2016

Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine

por Greene, Julia, Schneble, Erika, Martin, Jonathan, Flores, Maddie, Trappey, Alfred, Berry, John, Vreeland, Timothy, Hale, Diane, Clifton, Guy, Perez, Sonia A, Papamichail, Michael, Peoples, George, Mittendorf, Elizabeth, Ponniah, Sathibalan
Publicado 2014

Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients

por Schneble, Erika J, Berry, John S, Trappey, Alfred F, Vreeland, Timothy J, Hale, Diane F, Sears, Alan K, Clifton, Guy T, Ponniah, Sathibalan, Shumway, Nathan M, Mittendorf, Elizabeth A, Peoples, George E
Publicado 2013

Routine Pre-Treatment MRI for Breast Cancer in a Single-Payer Medical Center: Effects on Surgical Choices, Timing and Outcomes

por Vreeland, Timothy J, Berry IV, John S, Schneble, Erika, Jackson, Doreen O, Herbert, Garth S, Hale, Diane F, Martin, Jonathon M, Flores, Madeline, Pattyn, Adam R, Hata, Kai, Clifton, Guy T, Kirkpatrick, Aaron D, Peoples, George E.
Publicado 2017

Chemoprevention in familial adenomatous polyposis: past, present and future

por Kemp Bohan, Phillip M., Mankaney, Gautam, Vreeland, Timothy J., Chick, Robert C., Hale, Diane F., Cindass, Jessica L., Hickerson, Annelies T., Ensley, Daniel C., Sohn, Vance, Clifton, G. Travis, Peoples, George E., Burke, Carol A.
Publicado 2020

Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement

por Kemp Bohan, Phillip M., Chick, Robert C., Hickerson, Annelies T., Messersmith, Lynn M., Williams, Grant M., Cindass, Jessica L., Lombardo, Jamie, Collins, Ryan, Brady, Robert O., Hale, Diane F., Peoples, George E., Vreeland, Timothy J., Clifton, Guy T.
Publicado 2020

Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma

por McCarthy, Patrick M, Rendo, Matthew J, Uy, Matthew D, Adams, Alexandra M, O’Shea, Anne E, Nelson, Daniel William, Fenderson, Joshua L, Cebe, Katherine M, Krell, Robert W, Clifton, Guy T, Peoples, George E, Vreeland, Timothy J
Publicado 2021

Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials

por McCarthy, Patrick M., Valdera, Franklin A., Smolinsky, Todd R., Adams, Alexandra M., O’Shea, Anne E., Thomas, Katryna K., Van Decar, Spencer, Carpenter, Elizabeth L., Tiwari, Ankur, Myers, John W., Hale, Diane F., Vreeland, Timothy J., Peoples, George E., Stojadinovic, Alex, Clifton, Guy T.
Publicado 2023

Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients

por Brown, Tommy A., Byrd, Kevin, Vreeland, Timothy J., Clifton, Guy T., Jackson, Doreen O., Hale, Diane F., Herbert, Garth S., Myers, John W., Greene, Julia M., Berry, John S., Martin, Jonathan, Elkas, John C., Conrads, Thomas P., Darcy, Kathleen M., Hamilton, Chad A., Maxwel, George L., Peoples, George E.
Publicado 2019

A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis

por Vreeland, Timothy J., Clifton, Guy T., Hale, Diane F., Chick, Robert C., Hickerson, Annelies T., Cindass, Jessica L., Adams, Alexandra M., Bohan, Phillip M. Kemp, Andtbacka, Robert H. I., Berger, Adam C., Jakub, James W., Sussman, Jeffrey J., Terando, Alicia M., Wagner, Thomas, Peoples, George E., Faries, Mark B.
Publicado 2021

Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients

por Jackson, Doreen O., Byrd, Kevin, Vreeland, Timothy J., Hale, Diane F., Herbert, Garth S., Greene, Julia M., Schneble, Erika J., Berry, John S., Trappey, Alfred F., Travis Clifton, Guy, Hardin, Mark O., Martin, Jonathan, Elkas, John C., Conrads, Thomas P., Darcy, Kathleen M., Hamilton, Chad A., Maxwell, George L., Peoples, George E.
Publicado 2016

Multi‐institutional, prospective, randomized, double‐blind, placebo‐controlled phase IIb trial of the tumor lysate, particle‐loaded, dendritic cell (TLPLDC) vaccine to prevent recu...

por Chick, Robert C., Faries, Mark B., Hale, Diane F., Kemp Bohan, Phillip M, Hickerson, Annelies T., Vreeland, Timothy J., Myers, John W., Cindass, Jessica L., Brown, Tommy A., Hyngstrom, John, Berger, Adam C., Jakub, James W., Sussman, Jeffrey J., Shaheen, Montaser, Clifton, Guy T., Park, Hyohyun, Sloan, Amanda J., Wagner, Thomas, Peoples, George E.
Publicado 2021

Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence

por Brown, Tommy A., Mittendorf, Elizabeth A., Hale, Diane F., Myers, John W., Peace, Kaitlin M., Jackson, Doreen O., Greene, Julia M., Vreeland, Timothy J., Clifton, G. Travis, Ardavanis, Alexandros, Litton, Jennifer K., Shumway, Nathan M., Symanowski, J., Murray, James L., Ponniah, Sathibalan, Anastasopoulou, E. A., Pistamaltzian, N. F., Baxevanis, Constantin N., Perez, Sonia A., Papamichail, Michael, Peoples, George E.
Publicado 2020